Search research articles
Contact Us
Filters
Showing results (1-10 of 87) with videos related to
Page
of 9
Sort By:
Nature Cancer
|
July 26, 2022
PARP11 interfer(on)es with CAR T cell efficacy
Isabelle Munoz, Paul A Beavis
Current Opinion in Pharmacology
|
November 13, 2020
Editorial overview: Cancer 2020 current mechanistic insights into the hypoxia-adenosine-A2A adenosinergic immunosuppressive axis in cancer immunotherapies
Paul A Beavis, Stephen M Hatfield
Clinical & Translational Immunology
|
August 2, 2019
CAR T cells take centre stage
Paul A Beavis, Phillip K Darcy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Challenges of Creating New Tumor-Infiltrating Lymphocyte for Combating Breast Cancer
Paul A Beavis, Emily B Derrick, Sherene Loi
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 18, 2017
A Novel Target Antigen for the Treatment of Acute Myeloid Leukemia by CAR T Cells
Paul A Beavis, Kevin Sek, Phillip K Darcy
Cancer Cell
|
June 10, 2020
p38 Kinase: A Key Target for Driving Potent T Cells for Adoptive Immunotherapy
Jack D Chan, Paul A Beavis, Phillip K Darcy
Cancer Cell
|
December 13, 2024
A metabolic pathway for improving adoptive cellular therapy
Christina M Scheffler, Paul A Beavis, Phillip K Darcy
The FEBS Journal
|
March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNA
Imran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology
|
May 23, 2017
A novel combination strategy for effectively targeting cancer stem-like cells
Paul A Beavis, Emma V Petley, Phillip K Darcy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2020
Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines
Benjamin J Solomon, Paul A Beavis, Philip K Darcy
Page
of 9
Search research articles
Search
Showing results (1-10 of 87) with videos related to
Sort By:
Page
of 9
Nature Cancer
|
July 26, 2022
PARP11 interfer(on)es with CAR T cell efficacy
Isabelle Munoz, Paul A Beavis
Current Opinion in Pharmacology
|
November 13, 2020
Editorial overview: Cancer 2020 current mechanistic insights into the hypoxia-adenosine-A2A adenosinergic immunosuppressive axis in cancer immunotherapies
Paul A Beavis, Stephen M Hatfield
Clinical & Translational Immunology
|
August 2, 2019
CAR T cells take centre stage
Paul A Beavis, Phillip K Darcy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 19, 2022
Challenges of Creating New Tumor-Infiltrating Lymphocyte for Combating Breast Cancer
Paul A Beavis, Emily B Derrick, Sherene Loi
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
July 18, 2017
A Novel Target Antigen for the Treatment of Acute Myeloid Leukemia by CAR T Cells
Paul A Beavis, Kevin Sek, Phillip K Darcy
Cancer Cell
|
June 10, 2020
p38 Kinase: A Key Target for Driving Potent T Cells for Adoptive Immunotherapy
Jack D Chan, Paul A Beavis, Phillip K Darcy
Cancer Cell
|
December 13, 2024
A metabolic pathway for improving adoptive cellular therapy
Christina M Scheffler, Paul A Beavis, Phillip K Darcy
The FEBS Journal
|
March 24, 2018
Tumor-derived exosomes modulate T cell function through transfer of RNA
Imran G House, Emma V Petley, Paul A Beavis
Immunology and Cell Biology
|
May 23, 2017
A novel combination strategy for effectively targeting cancer stem-like cells
Paul A Beavis, Emma V Petley, Phillip K Darcy
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 16, 2020
Promising Immuno-Oncology Options for the Future: Cellular Therapies and Personalized Cancer Vaccines
Benjamin J Solomon, Paul A Beavis, Philip K Darcy
Page
of 9